{"title": "Ivermectina dentro del protocolo de tratamiento para la COVID-19 en Per\u00fa: Uso sin evidencia cient\u00edfica", "author": "Jes\u00fas Lescano; Chris Pinto", "url": null, "hostname": null, "description": "Ivermectin is one of the most widely used antiparasitic drugs in veterinary medicine. Moreover, it is used for treating many parasitosis in human medicine. However, its uncontrolled massive use is being associated to the appearance of parasitic resistance. The emergence of SARS-CoV-2, causing agent of COVID-19, has challenged health systems worldwide, forcing them to urgently work in the development of proper therapeutic protocols against such disease. In Peru, the Ministry of Health approved the addition of ivermectin within the treatment protocol for COVID-19. Aiming to collect scientific evidence that supported such decision, a systematic search was performed within scientific journals\u00b4 digital repositories and clinical trials\u00b4 databases focused on therapy against COVID-19. Until the date of submission of this article, no scientific evidence was found to support the efficacy or safety of using ivermectin as treatment against SARS-CoV-2 in humans. Solely an in vitro study was found as suggestive evidence, but its replication in people would be unlikely as it would be necessary to administer considerably higher doses of the drug than those approved for use in humans. Additionally, some clinical trials are currently assessing the addition of ivermectin in COVID-19 patients, but their results have not been published yet. Finally, this article describes both the possible consequences of the generalized misinformation regarding the use of ivermectin against COVID-19 added to the permissibility for using veterinary products containing such drug in human patients, as well as the important role of veterinarians in this situation.", "sitename": "Salud y Tecnolog\u00eda Veterinaria", "date": "2020-08-17", "id": null, "license": "CC BY 4.0", "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Ivermectina dentro del protocolo de tratamiento para la COVID-19 en Per\u00fa: Uso sin evidencia cient\u00edfica\nResumen\nIvermectina es uno de los f\u00e1rmacos antiparasitarios m\u00e1s ampliamente utilizados en medicina veterinaria. Asimismo, en medicina humana es utilizada en el tratamiento de diversas parasitosis. Sin embargo, su uso masivo sin control viene siendo asociado a la presentaci\u00f3n de resistencia parasitaria. La emergencia del SARS-CoV-2, causante de la COVID-19, ha desafiado a los sistemas de salud a nivel mundial, forz\u00e1ndolos a trabajar urgentemente en el desarrollo de protocolos de tratamiento adecuados para dicha enfermedad. En el Per\u00fa, el Ministerio de Salud dispuso la inclusi\u00f3n de ivermectina dentro del protocolo de tratamiento contra la COVID-19. Con el objetivo de conocer la evidencia cient\u00edfica que respalda dicha medida, se realiz\u00f3 una b\u00fasqueda sistem\u00e1tica en repositorios digitales de revistas cient\u00edficas y en las bases de datos de ensayos cl\u00ednicos enfocados en tratamientos contra la COVID-19. Hasta la fecha de remisi\u00f3n de este art\u00edculo, no se encontr\u00f3 evidencia cient\u00edfica que respalde la eficacia ni seguridad del uso de ivermectina como tratamiento contra el SARS-CoV-2 en seres humanos. El \u00fanico indicio es un estudio in vitro, cuya replicaci\u00f3n en pacientes seria poco probable debido a que se necesitar\u00edan usar dosis considerablemente m\u00e1s altas que aquellas actualmente aprobadas para consumo humano. Adicionalmente, se encontr\u00f3 registro de algunos ensayos cl\u00ednicos evaluando la inclusi\u00f3n de ivermectina en pacientes COVID-19, cuyos resultados a\u00fan no han sido publicados. Finalmente, este art\u00edculo describe tanto las consecuencias que podr\u00edan tener la desinformaci\u00f3n generalizada respecto a ivermectina como tratamiento contra la COVID-19 sumada a la permisibilidad de que productos veterinarios conteniendo dicho principio activo sean empleados en pacientes humanos, as\u00ed como, el importante rol de los M\u00e9dicos Veterinarios en esta situaci\u00f3n.\nDerechos de autor 2020 Jes\u00fas Lescano, Chris Pinto\nEsta obra est\u00e1 bajo licencia internacional\n[Creative Commons Reconocimiento 4.0](http://creativecommons.org/licenses/by/4.0/).\nTodos los art\u00edculos publicados en la Salud y Tecnolog\u00eda Veterinaria est\u00e1n protegidos por una una licencia\n[Creative Commons Reconocimiento 4.0 Internacional](https://creativecommons.org/licenses/by/4.0/).\nLos autores conservan los derechos de autor y ceden a la revista el derecho de primera publicaci\u00f3n, con el trabajo registrado con la Licencia de Creative Commons, que permite a terceros utilizar lo publicado siempre que mencionen la autor\u00eda del trabajo, y a la primera publicaci\u00f3n en esta revista.\nLos autores pueden realizar otros acuerdos contraactuales independientes y adicionales para la distribuci\u00f3n no exclusiva de la versi\u00f3n publicada en esta revista, siempre que indiquen claramente que el trabajo se public\u00f3 en esta revista.\nLos autores puede archivar en el repositorio de su instituci\u00f3n:\nEl trabajo de investigaci\u00f3n o tesis de grado del que deriva el art\u00edculo publicado.\nLa versi\u00f3n preimpresa: la versi\u00f3n previa a la revisi\u00f3n por pares.\nLa versi\u00f3n posterior a la impresi\u00f3n: versi\u00f3n final despu\u00e9s de la revisi\u00f3n por pares.\nLa versi\u00f3n definitiva o versi\u00f3n final creada por el editor para su publicaci\u00f3n.", "language": null, "image": null, "pagetype": null, "links": ["#pkp_content_main", "#pkp_content_nav", "#pkp_content_footer", "https://revistas.upch.edu.pe/index.php/STV/index", "https://revistas.upch.edu.pe/index.php/STV/about", "https://revistas.upch.edu.pe/index.php/STV/about", "https://revistas.upch.edu.pe/index.php/STV/peerreview", "https://revistas.upch.edu.pe/index.php/STV/Copyright", "https://revistas.upch.edu.pe/index.php/STV/exemption", "https://revistas.upch.edu.pe/index.php/STV/accesoabierto", "https://revistas.upch.edu.pe/index.php/STV/nofees", "https://revistas.upch.edu.pe/index.php/STV/politicassobreplagio", "https://revistas.upch.edu.pe/index.php/STV/etica", "https://revistas.upch.edu.pe/index.php/STV/preservacion", "https://revistas.upch.edu.pe/index.php/STV/about/privacy", "https://revistas.upch.edu.pe/index.php/STV/about/contact", "https://revistas.upch.edu.pe/index.php/STV/about/editorialTeam", "https://revistas.upch.edu.pe/index.php/STV/issue/current", "https://revistas.upch.edu.pe/index.php/STV/issue/archive", "https://revistas.upch.edu.pe/index.php/STV/about/submissions", "https://revistas.upch.edu.pe/index.php/STV/announcement", "https://revistas.upch.edu.pe/index.php/STV/search/search", "#", "https://revistas.upch.edu.pe/index.php/STV/user/register", "https://revistas.upch.edu.pe/index.php/STV/login", "https://jornadas.cayetano.edu.pe/", "https://revistas.upch.edu.pe/index.php/STV/index", "https://revistas.upch.edu.pe/index.php/STV/issue/archive", "https://revistas.upch.edu.pe/index.php/STV/issue/view/387", "https://orcid.org/0000-0001-6478-7437", "https://orcid.org/0000-0002-2123-2762", "https://doi.org/10.20453/stv.v8i1.3789", "https://revistas.upch.edu.pe/index.php/STV/article/view/3789/4217", "https://revistas.upch.edu.pe/index.php/STV/article/view/3789/4223", "https://revistas.upch.edu.pe/index.php/STV/citationstylelanguage/get/acm-sig-proceedings?submissionId=3789", "https://revistas.upch.edu.pe/index.php/STV/citationstylelanguage/get/acs-nano?submissionId=3789", "https://revistas.upch.edu.pe/index.php/STV/citationstylelanguage/get/apa?submissionId=3789", "https://revistas.upch.edu.pe/index.php/STV/citationstylelanguage/get/associacao-brasileira-de-normas-tecnicas?submissionId=3789", "https://revistas.upch.edu.pe/index.php/STV/citationstylelanguage/get/chicago-author-date?submissionId=3789", "https://revistas.upch.edu.pe/index.php/STV/citationstylelanguage/get/harvard-cite-them-right?submissionId=3789", "https://revistas.upch.edu.pe/index.php/STV/citationstylelanguage/get/ieee?submissionId=3789", "https://revistas.upch.edu.pe/index.php/STV/citationstylelanguage/get/modern-language-association?submissionId=3789", "https://revistas.upch.edu.pe/index.php/STV/citationstylelanguage/get/turabian-fullnote-bibliography?submissionId=3789", "https://revistas.upch.edu.pe/index.php/STV/citationstylelanguage/get/vancouver?submissionId=3789", "https://revistas.upch.edu.pe/index.php/STV/citationstylelanguage/download/ris?submissionId=3789", "https://revistas.upch.edu.pe/index.php/STV/citationstylelanguage/download/bibtex?submissionId=3789", "https://revistas.upch.edu.pe/index.php/STV/issue/view/387", "http://creativecommons.org/licenses/by/4.0/", "http://creativecommons.org/licenses/by/4.0/", "https://creativecommons.org/licenses/by/4.0/", "https://investigacion.cayetano.edu.pe/noticias/conoce-que-trae-el-dia-2-de-jornadas-cientificas-2023/", "https://revistas.upch.edu.pe/index.php/STV/user/setLocale/es_ES?source=%2Findex.php%2FSTV%2Farticle%2Fview%2F3789", "https://revistas.upch.edu.pe/index.php/STV/user/setLocale/en_US?source=%2Findex.php%2FSTV%2Farticle%2Fview%2F3789", "https://revistas.upch.edu.pe/index.php/STV/user/setLocale/pt_BR?source=%2Findex.php%2FSTV%2Farticle%2Fview%2F3789", "https://www.latindex.org/latindex/Solr/Busqueda?idModBus=0&buscar=2312-3907&submit=Buscar", "https://v2.sherpa.ac.uk/id/publication/39392", "http://portal.revistas.bvs.br/index.php?issn=2312-3907&lang=pt", "https://acortar.link/jLBHCP", "https://investigacion.cayetano.edu.pe/noticias/conversatorio-1-revistas-cientificas-de-acceso-abierto-como-medio-de-difusion-de-conocimientos/", "https://veterinaria.cayetano.edu.pe/", "http://creativecommons.org/licenses/by/4.0/", "http://creativecommons.org/licenses/by/4.0/", "https://revistas.upch.edu.pe/index.php/STV/about/aboutThisPublishingSystem"]}